J&J’s Caplyta doubles remission rate in MDD patients
J&J presented the new analysis from three Phase III trials of Caplyta in MDD.
JPM26: Eli Lilly highlights Lp(a) drugs as cardiovascular growth focus
Ocugen sets sights on Phase III after GA gene therapy win
Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management
QPS adopts Oracle Argus to advance safety in clinical trials
FDA and EMA release collaborative AI framework for drug development
Analysis
View More
Themes
View MoreRevealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
91% of clinical research associates concerned with burnout and turnover, third-party data query resolution can cost sponsors millions.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Patient-centric approaches thrive on wearables and remote access in trials
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment